Journal articleCancer Res2019
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.
- Journal
- Cancer Res
- Published
- 1 May 2019
- Citations
- 33
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Stem Cell Biology & Cellular Therapy Program P30CA016672↗
- Administrative Core P50CA221707↗
- Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation R01CA207236↗
- Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer R01CA218004↗
- Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer R01CA227517↗